What is a stock summary page? Click here for an overview.
Business Description
Apex Healthcare Bhd
ISIN : MYL7090OO003
Compare
Compare
Traded in other countries / regions
7090.Malaysia IPO Date
2000-06-26Description
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing and marketing of pharmaceutical products; Wholesale and distribution of pharmaceutical and healthcare products; and Corporate comprising investments, properties, and others. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.77 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.46 | |||||
| Interest Coverage | 69.41 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 6.8 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.4 | |||||
| 3-Year EBITDA Growth Rate | 10.2 | |||||
| 3-Year EPS without NRI Growth Rate | 8.8 | |||||
| 3-Year Book Growth Rate | 15.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.28 | |||||
| 9-Day RSI | 49.68 | |||||
| 14-Day RSI | 43.19 | |||||
| 3-1 Month Momentum % | -6.88 | |||||
| 6-1 Month Momentum % | -16.36 | |||||
| 12-1 Month Momentum % | -22.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.32 | |||||
| Quick Ratio | 2.5 | |||||
| Cash Ratio | 1.31 | |||||
| Days Inventory | 66.22 | |||||
| Days Sales Outstanding | 73.97 | |||||
| Days Payable | 73.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.83 | |||||
| Dividend Payout Ratio | 0.79 | |||||
| 3-Year Dividend Growth Rate | 34.4 | |||||
| Forward Dividend Yield % | 4.25 | |||||
| 5-Year Yield-on-Cost % | 9.72 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 1.18 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.46 | |||||
| Operating Margin % | 10.14 | |||||
| Net Margin % | 7.96 | |||||
| FCF Margin % | -1.24 | |||||
| ROE % | 8.99 | |||||
| ROA % | 7.23 | |||||
| ROIC % | 11.92 | |||||
| 3-Year ROIIC % | 9.28 | |||||
| ROC (Joel Greenblatt) % | 25.97 | |||||
| ROCE % | 11.61 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.63 | |||||
| PE Ratio without NRI | 19.63 | |||||
| Shiller PE Ratio | 14.75 | |||||
| Price-to-Owner-Earnings | 47.11 | |||||
| PEG Ratio | 0.86 | |||||
| PS Ratio | 1.58 | |||||
| PB Ratio | 1.93 | |||||
| Price-to-Tangible-Book | 1.96 | |||||
| Price-to-Operating-Cash-Flow | 22.08 | |||||
| EV-to-EBIT | 13.35 | |||||
| EV-to-EBITDA | 11.01 | |||||
| EV-to-Revenue | 1.42 | |||||
| EV-to-FCF | -114.47 | |||||
| Price-to-GF-Value | 0.8 | |||||
| Price-to-Projected-FCF | 1.34 | |||||
| Price-to-DCF (Earnings Based) | 0.75 | |||||
| Price-to-Median-PS-Value | 0.98 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.79 | |||||
| Price-to-Graham-Number | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 4.71 | |||||
| Earnings Yield (Greenblatt) % | 7.49 | |||||
| FCF Yield % | -0.78 | |||||
| Forward Rate of Return (Yacktman) % | 22.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apex Healthcare Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 961.78 | ||
| EPS (TTM) (RM) | 0.108 | ||
| Beta | 0.56 | ||
| 3-Year Sharpe Ratio | 0.32 | ||
| 3-Year Sortino Ratio | 0.5 | ||
| Volatility % | 18.82 | ||
| 14-Day RSI | 43.19 | ||
| 14-Day ATR (RM) | 0.049383 | ||
| 20-Day SMA (RM) | 2.1215 | ||
| 12-1 Month Momentum % | -22.56 | ||
| 52-Week Range (RM) | 1.98 - 3.42 | ||
| Shares Outstanding (Mil) | 720.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apex Healthcare Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apex Healthcare Bhd Stock Events
| Event | Date | Price (RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
Apex Healthcare Bhd Frequently Asked Questions
What is Apex Healthcare Bhd(XKLS:7090)'s stock price today?
The current price of XKLS:7090 is RM2.12. The 52 week high of XKLS:7090 is RM3.42 and 52 week low is RM1.98.
When is next earnings date of Apex Healthcare Bhd(XKLS:7090)?
The next earnings date of Apex Healthcare Bhd(XKLS:7090) is .
Does Apex Healthcare Bhd(XKLS:7090) pay dividends? If so, how much?
The Dividend Yield %  of Apex Healthcare Bhd(XKLS:7090) is 2.83% (As of Today), Highest Dividend Payout Ratio of Apex Healthcare Bhd(XKLS:7090) was 0.79. The lowest was 0.09. And the median was 0.32. The  Forward Dividend Yield % of Apex Healthcare Bhd(XKLS:7090) is 4.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers